Novartis and GSK have recently agreed that GSK takes over vaccine division of Novartis, and Novartis takes over Oncology Business Unit of GSK
Novartis and GSK have recently agreed that GSK takes over vaccine division of Novartis, and Novartis takes over Oncology Business Unit of GSK. In addition, the two companies decided to proceed with sales of OTC items through the establishment of joint venture. GSK has a 63.5% of stake.
This situ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
